Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Steven Sun"'
Autor:
Lakshmi Prabhu, Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang, Aishat Motolani, Mengyao Sun, Guanglong Jiang, Harikrishna Nakshatri, Melissa L. Fishel, Steven Sun, Ahmad Safa, Rommie E. Amaro, Mark R. Kelley, Yunlong Liu, Zhong-Yin Zhang, Tao Lu
Publikováno v:
Genes and Diseases, Vol 10, Iss 1, Pp 267-283 (2023)
Market drugs, such as Food and Drug Administration (FDA) or European Medicines Agency (EMA)-approved drugs for specific indications provide opportunities for repurposing for newer therapeutics. This potentially saves resources invested in clinical tr
Externí odkaz:
https://doaj.org/article/c1b0c6c6e2c44a04afeb6c77405f86a9
Autor:
Jun Zhu, Xiaonan Hong, Yu Qin Song, Brendan Hodkinson, Sriram Balasubramanian, Songbai Wang, Qingyuan Zhang, Yuankai Shi, Huiqiang Huang, Huilai Zhang, Yan Zhu, Stephen Martin Shreeve, Steven Sun, Ze Wang, Xiaocan Wang, Yue Fan, Wyndham Wilson, Jessica Vermeulen
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1154-1164 (2022)
Abstract In this post hoc subgroup analysis of 200 patients enrolled in China from the phase III PHOENIX trial (N = 838, NCT01855750), addition of ibrutinib to rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) did no
Externí odkaz:
https://doaj.org/article/c5c60059677a4edd904790870a35470b
Autor:
Sriram Balasubramanian, Brendan Hodkinson, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Bruce D. Cheson, Michael Schaffer, Steven Sun, Sanjay Deshpande, Jessica Vermeulen, Gilles Salles, Ajay K. Gopal
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 61-73 (2022)
Abstract Background The single‐arm DAWN trial (NCT01779791) of ibrutinib monotherapy in patients with relapsed/refractory follicular lymphoma (FL) showed an overall response rate (ORR) of 20.9% and a median response duration of 19.4 months. This bi
Externí odkaz:
https://doaj.org/article/8e668f1ebce046fb90165c45e83463d9
Autor:
Matthew Martin, Rasika Mundade, Antja-Voy Hartley, Guanglong Jiang, Jiamin Jin, Steven Sun, Ahmad Safa, George Sandusky, Yunlong Liu, Tao Lu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2732 (2022)
Since nuclear factor (NF) κB plays pivotal roles in inflammation and cancer, understanding its regulation holds great promise for disease therapy. Using the powerful validation-based insertional mutagenesis (VBIM) technique established by us previou
Externí odkaz:
https://doaj.org/article/94574ff402ef4ea2ad901137b97ebf63
Autor:
Qinyu Chen MHS, Eliza W Beal MD, MS, Victor Okunrintemi MD, MPH, Emily Cerier BS, Anghela Paredes MD, Steven Sun MD, Griffin Olsen BA, Timothy M Pawlik MD, MPH, PhD
Publikováno v:
Journal of Patient Experience, Vol 6 (2019)
Objective: Although patient satisfaction is increasingly used to rate hospitals, it is unclear how patient satisfaction is associated with health outcomes. We sought to define the relationship of self-reported patient satisfaction and health outcomes
Externí odkaz:
https://doaj.org/article/f59f33074bc046a3a72e9dcd36e28642
Autor:
Antja-Voy Hartley, Benlian Wang, Guanglong Jiang, Han Wei, Mengyao Sun, Lakshmi Prabhu, Matthew Martin, Ahmad Safa, Steven Sun, Yunlong Liu, Tao Lu
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 10, p 3684 (2020)
The overexpression of PRMT5 is highly correlated to poor clinical outcomes for colorectal cancer (CRC) patients. Importantly, our previous work demonstrated that PRMT5 overexpression could substantially augment activation of the nuclear factor kappa
Externí odkaz:
https://doaj.org/article/24e48fc7c35b48079267efbffa325aa9
Autor:
Craig P Giacomini, Steven Sun, Sushama Varma, A Hunter Shain, Marilyn M Giacomini, Jay Balagtas, Robert T Sweeney, Everett Lai, Catherine A Del Vecchio, Andrew D Forster, Nicole Clarke, Kelli D Montgomery, Shirley Zhu, Albert J Wong, Matt van de Rijn, Robert B West, Jonathan R Pollack
Publikováno v:
PLoS Genetics, Vol 9, Iss 4, p e1003464 (2013)
Gene fusions, like BCR/ABL1 in chronic myelogenous leukemia, have long been recognized in hematologic and mesenchymal malignancies. The recent finding of gene fusions in prostate and lung cancers has motivated the search for pathogenic gene fusions i
Externí odkaz:
https://doaj.org/article/92ff14bb419441ca9049ba522a6d3f11
Publikováno v:
Lab on a Chip; 8/21/2010, Vol. 10 Issue 16, p2093-2100, 8p
Publikováno v:
Lab on a Chip; Nov2009, Vol. 9 Issue 22, p3275-3281, 7p
Publikováno v:
Surgical Infections; Apr2007, Vol. 8 Issue 2, p159-172, 1p